Search research articles
Contact Us
Filters
Showing results (1-10 of 94) with videos related to
Page
of 10
Sort By:
Current Stem Cell Research & Therapy
|
January 29, 2008
The impact of new emerging drugs in the treatment of multiple myeloma: is there still a role for PBSC transplantation?
Alessandro Corso, Marzia Varettoni
Hematology/Oncology Clinics of North America
|
May 28, 2023
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia
Marzia Varettoni, Jeffrey V Matous
Expert Opinion on Pharmacotherapy
|
June 14, 2021
Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma
Chiara Cavalloni, Marzia Varettoni, Sara Rattotti, et al.
Frontiers in Medicine
|
August 27, 2024
Erythrocytosis in congenital heart defects: hints for diagnosis and therapy from a clinical case
Oscar Borsani, Marzia Varettoni, Giacomo Riccaboni, et al.
Leukemia Research
|
August 14, 2009
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients
Alessandro Corso, Silvia Mangiacavalli, Marzia Varettoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
November 29, 2017
Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature
Marzia Varettoni, Irene Defrancesco, Luca Diamanti, et al.
Expert Review of Hematology
|
October 31, 2023
New developments in the diagnosis and characterization of Waldenström's macroglobulinemia
Ramón García-Sanz, Zachary R Hunter, Stéphanie Poulain, et al.
Hematological Oncology
|
May 11, 2023
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel
Pier Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, et al.
Hematological Oncology
|
February 16, 2024
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panel
Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, et al.
Medicine
|
July 10, 2010
Changing pattern of presentation in monoclonal gammopathy of undetermined significance: a single-center experience with 1400 patients
Marzia Varettoni, Alessandro Corso, Federica Cocito, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 94) with videos related to
Sort By:
Page
of 10
Current Stem Cell Research & Therapy
|
January 29, 2008
The impact of new emerging drugs in the treatment of multiple myeloma: is there still a role for PBSC transplantation?
Alessandro Corso, Marzia Varettoni
Hematology/Oncology Clinics of North America
|
May 28, 2023
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia
Marzia Varettoni, Jeffrey V Matous
Expert Opinion on Pharmacotherapy
|
June 14, 2021
Evaluating ibrutinib for the treatment of relapsed/refractory marginal zone lymphoma
Chiara Cavalloni, Marzia Varettoni, Sara Rattotti, et al.
Frontiers in Medicine
|
August 27, 2024
Erythrocytosis in congenital heart defects: hints for diagnosis and therapy from a clinical case
Oscar Borsani, Marzia Varettoni, Giacomo Riccaboni, et al.
Leukemia Research
|
August 14, 2009
Bortezomib-induced peripheral neuropathy in multiple myeloma: a comparison between previously treated and untreated patients
Alessandro Corso, Silvia Mangiacavalli, Marzia Varettoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
November 29, 2017
Bing-Neel Syndrome: Illustrative Cases and Comprehensive Review of the Literature
Marzia Varettoni, Irene Defrancesco, Luca Diamanti, et al.
Expert Review of Hematology
|
October 31, 2023
New developments in the diagnosis and characterization of Waldenström's macroglobulinemia
Ramón García-Sanz, Zachary R Hunter, Stéphanie Poulain, et al.
Hematological Oncology
|
May 11, 2023
Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel
Pier Luigi Zinzani, Francesca Romana Mauro, Alessandra Tedeschi, et al.
Hematological Oncology
|
February 16, 2024
Identifying and addressing unmet clinical needs on the use of zanubrutinib in chronic lymphocytic leukemia: A consensus-based position paper from an ad hoc expert panel
Francesca Romana Mauro, Alessandra Tedeschi, Marzia Varettoni, et al.
Medicine
|
July 10, 2010
Changing pattern of presentation in monoclonal gammopathy of undetermined significance: a single-center experience with 1400 patients
Marzia Varettoni, Alessandro Corso, Federica Cocito, et al.
Page
of 10